TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid InChi: InChI=1S/C25H29N3O3/c1-17-22(19-14-23(29-2)25(31-4)24(15-19)30-3)13-20(16-27-17)18-5-7-21(8-6-18)28-11-9-26-10-12-28/h5-8

InChi: InChI=1S/C25H29N3O3/c1-17-22(19-14-23(29-2)25(31-4)24(15-19)30-3)13-20(16-27-17)18-5-7-21(8-6-18)28-11-9-26-10-12-28/h5-8

Molecular Weight: 354

Smiles: CN(C1C=CC(=CC=1)C(F)(F)F)C(=O)C1=C(O)C2C(=CC=CC=2N(C)C1=O)OC

The Evolving Landscape in the Development of Isocitrate Dehydrogenase Mutant Inhibitors

PluriSIn-1 was identified by a high-throughput screening against undifferentiated human ESCs

TMP269 - Class IIa HDAC Inhibitor. CAS# 1314890-29-3 size:10mg solid InChi: InChI=1S/C25H29N3O3/c1-17-22(19-14-23(29-2)25(31-4)24(15-19)30-3)13-20(16-27-17)18-5-7-21(8-6-18)28-11-9-26-10-12-28/h5-8TMP269, CAS No. 1314890 29 3, is a highly potent, selective and cell permeable class IIa HDAC inhibitor with IC50 of 126 nM, 80 nM, 36 nM and 19 nM for HDAC4, HDAC5, HDAC7 and HDAC9 respectively. It has very weak or no activity targeting the other HDACs (2 40 M). TMP269 has an unprecedented metal binding group, trifluoromethyloxadiazole (TFMO), which circumvents the selectivity and pharmacologic liabilities of hydroxamates. Crystallography revealed a